Mechanisms causing CIMP are heterogeneous, including mutations in IDH1/2 and SETD2 that were previously reported in specific cancer types, as well as reported for the first time here in new cancer types; the novel overexpression of BORIS/CTCFL spanned several cancer types. This evidence concerns the gene IDH1 and cancer.